Advertisement

Annals of Vascular Surgery

, Volume 8, Issue 6, pp 583–590 | Cite as

Catheter-directed thrombolysis following vena cava filtration for severe deep venous thrombosis

  • Wallace C. Tarry
  • Raymond G. Makhoul
  • Jaime Tisnado
  • Marc P. Posner
  • Michael Sobel
  • H. M. Lee
Case Reports

Abstract

Massive deep venous thrombosis with marked venous outflow obstruction can result in limb loss or end-organ injury. Systemically administered drugs may not reach thrombi in therapeutic concentrations and surgical and thrombolytic strategies carry a small but real risk of pulmonary embolus—similar to the risks with anticoagulation alone. We therefore developed a strategy in which catheter-directed thrombolysis was used to deliver high concentrations of a plasminogen activator directly to the thrombus combined with placement of a downstream Greenfield filter to protect patients from pulmonary embolus. From 1984 to 1993 six patients were treated with this regimen. All had severe symptoms of less than 4 days' duration. On radiologic evaluation four patients had large iliofemoral and/or inferior vena cava thrombosis, one had subclavian/innominate vein thrombosis, and one had transplant renal vein/iliofemoral/inferior vena cava thrombosis. A Greenfield filter was first placed downstream prior to imbedding an infusion catheter in the greatest mass of thrombus for subsequent infusion of urokinase (n=4) or streptokinase (n=2). In four patients the catheter traversed the Greenfield filter. All patients were given bolus lytic therapy followed by maintenance infusions ranging in duration from 24 hours to 12 days. Five patients remained on heparin simultaneously. Clot lysis was achieved in all patients with hemodynamic, symptomatic, and arteriographic improvement. There were no deaths, pulmonary emboli, or complications of filter placement. One patient had minor bleeding at the puncture site and another had catheter-related infection. At follow-up ranging from 8 months to 9 years all patients are asymptomatic with patent venous systems confirmed by duplex ultrasound imaging. Thus catheter-directed thrombolysis combined with vena cava filtration offers a safe and effective alternative to simple anticoagulation, surgery, or systemic thrombolysis. This approach may warrant more frequent use in patients with severe and disabling thrombosis of major deep veins.

Keywords

Pulmonary Embolus Plasminogen Activator Deep Venous Thrombosis Streptokinase Venous Outflow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Smith BM, Shield GW, Riddell DH, et al. Venous gangrene of the upper extremity. Ann Surg 1985;201:511–519.PubMedGoogle Scholar
  2. 2.
    Coon WW, Willis PW. Deep venous thrombosis and pulmonary embolism. Am J Cardiol 1959;4:611–621.CrossRefPubMedGoogle Scholar
  3. 3.
    Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975;17:259–270.PubMedGoogle Scholar
  4. 4.
    Nicolaides AN, Kakkar W, Field ES, et al. The origin of deep vein thrombosis: A venographic study. Br J Radiol 1971;44:653–663.PubMedCrossRefGoogle Scholar
  5. 5.
    Rutherford RB. Role of surgery in iliofemoral thrombosis. Chest 1976;5:4345–4375.Google Scholar
  6. 6.
    Hill SL, Martin D, Evans P. Massive venous thrombosis of the extremities. Am J Surg 1989;158:131–135.CrossRefPubMedGoogle Scholar
  7. 7.
    Pollak EW, Sparks FC, Barker WF. Pulmonary embolism. Arch Surg 1973;107:66–68.PubMedGoogle Scholar
  8. 8.
    Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial. Br J Surg 1979;66:838–843.PubMedGoogle Scholar
  9. 9.
    Tsapogas MJ, Peabody RA, Wu KT, et al. Controlled study of thrombolytic therapy in deep vein thrombosis. Surgery 1973;74:973–984.PubMedGoogle Scholar
  10. 10.
    Urokinase-Pulmonary Embolism Trial. Circulation 1973;47 (Suppl II):1–108.Google Scholar
  11. 11.
    Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Scand 1982;211:65–68.PubMedCrossRefGoogle Scholar
  12. 12.
    Watz R, Savidge GF. Rapid thrombolysis and preservation of valvular venous function in high deep vein thrombosis. Acta Med Scand 1979;205:293–298.PubMedCrossRefGoogle Scholar
  13. 13.
    Goldhaber SZ. Thrombolysis in venous thromboembolism. Chest 1990;97:176S-181S.PubMedGoogle Scholar
  14. 14.
    Common HH, Seaman AJ, Rosch J, et al. Deep vein thrombosis treated with streptokinase or heparin: Follow-up of a randomized study. Angiology 1976;27:645–654.PubMedGoogle Scholar
  15. 15.
    Browse NL, Thomas ML, Pim HP. Streptokinase and deep vein thrombosis. Br Med J 1968;3:717–720.PubMedCrossRefGoogle Scholar
  16. 16.
    Kakkar VV, Flanc C, Howe CT, et al. Treatment of deep vein thrombosis. A trial of heparin, streptokinase and arvin. Br Med J 1969;1:806–810.PubMedGoogle Scholar
  17. 17.
    Goldhaber SZ, Buring JE, Lipnick RJ, et al. Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984;76:393–397.CrossRefPubMedGoogle Scholar
  18. 18.
    Goldhaber SZ, Meyerovitz MF, Green D, et al. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med 1990;88:235–240.CrossRefPubMedGoogle Scholar
  19. 19.
    Turpie AGG, Levine MN, Hirsh J, et al. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Chest 1990;97:172S-175S.PubMedGoogle Scholar
  20. 20.
    Comerota J, Aldridge SC. Thrombolytic therapy for acute deep vein thrombosis. Semin Vasc Surg 1992;5:76–81.Google Scholar
  21. 21.
    Ryan CA, Andrew M. Failure of thrombolytic therapy in four children with extensive thrombosis. Am J Dis Child 1992;146:187–193.PubMedGoogle Scholar
  22. 22.
    Goldsmith JC, Lollar P, Hoak JC. Massive fatal pulmonary emboli with fibrinolytic therapy. Circulation 1982;64:1068–1069.Google Scholar
  23. 23.
    Verstraete M, Bernard R, Bory M, et al. Randomized trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Lancet 1985;1:842–847.CrossRefPubMedGoogle Scholar
  24. 24.
    Verhaeghe R, Besse P, Bounameaux H, et al. Multicenter pilot study of the efficacy and safety of systemic rt-pa administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis. Thromb Res 1989;55:5–11.CrossRefPubMedGoogle Scholar
  25. 25.
    Passamani E. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985;312:932–936.PubMedCrossRefGoogle Scholar
  26. 26.
    Califf RM, Topol EJ, George BS, et al. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med 1988;85:353–359.CrossRefPubMedGoogle Scholar
  27. 27.
    Fennerty AG, Levine MN, Hirsh J. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 1989;95:88S-97S.PubMedGoogle Scholar
  28. 28.
    Bounameaux H, Banga JD, Bluhmki E, et al. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 hr of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: Results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) Trial. Thromb Haemost 1992;67:306–309.PubMedGoogle Scholar
  29. 29.
    Sullivan KL, Gardiner GA, Shapiro MJ, et al. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 1989;173:805–808.PubMedGoogle Scholar
  30. 30.
    McNamara TO, Fischer JR. Thrombolysis of peripheral arterial and graft occlusions: Improved results using high-dose urokinase. AJR 1985;144:769–775.PubMedGoogle Scholar
  31. 31.
    McNamara TO. Role of thrombolysis in peripheral arterial occlusion. Am J Med 1987;83:6–10.CrossRefPubMedGoogle Scholar
  32. 32.
    Pernes JM, Vitoux JF, Brenoit P, et al. Acute peripheral arterial and graft occlusion: Treatment with selective infusion of urokinase and lysyl plasminogen. Radiology 1986;158:481–485.PubMedGoogle Scholar
  33. 33.
    McNamara TO, Bomberger RA, Merchant RF. Intra-arterial urokinase as the. initial therapy for acutely ischemic lower limbs. Circulation 1991;83(Suppl I):I-106–I-119.Google Scholar
  34. 34.
    DeMaioribus CA, Mills JL, Fujitani RM, et al. A reevaluation of intraarterial thrombolytic therapy for acute lower extremity ischemia. J Vasc Surg 1993;17:888–895.CrossRefPubMedGoogle Scholar
  35. 35.
    Savelyev VS, Yablokov EG, Dirienko AI, et al. Surgical prevention of pulmonary embolism. World J Surg 1980;4:709–716.PubMedGoogle Scholar
  36. 36.
    Andriopoulos A, Wirsing P, Botticher R. Results of iliofemoral venous thrombectomy after acute thrombosis. J Cardiovasc Surg 1982;23:123–124.Google Scholar
  37. 37.
    Haller JA, Abrams BL. Use of thrombectomy in the treatment of acute iliofemoral venous thrombosis in forty-five patients. Ann Surg 1963;158:561–569.PubMedCrossRefGoogle Scholar
  38. 38.
    Lord RSA, Chem FC, Devine TJ, et al. Surgical treatment of acute deep venous thrombosis. World J Surg 1990;14:694–702.CrossRefPubMedGoogle Scholar
  39. 39.
    Einarsson E, Albrechtsson U, Eklof B, et al. Follow-up evaluation of venous morphologic factors and function after thrombectomy and temporary arteriovenous fistula in thrombosis of iliofemoral vein. Surg Gynecol Obstet 1986;163:111–116.PubMedGoogle Scholar
  40. 40.
    Plate G, Einarsson E, Ohlin P, et al. Thrombectomy with temporary arteriovenous fistula: The treatment of choice in acute iliofemoral venous thrombosis. J Vasc Surg 1984;1:867–876.CrossRefPubMedGoogle Scholar
  41. 41.
    Greenfield LJ, Peyton R, Crute S, et al. Greenfield vena caval filter experience. Arch Surg 1981;116:1451–1456.PubMedGoogle Scholar
  42. 42.
    Gomez GA, Cutler BS, Wheeler HB. Transvenous interruption of the inferior vena cava. Surgery 1983;93:612–619.PubMedGoogle Scholar
  43. 43.
    Thery C, Asseman P, Amrouni N, et al. Use of a new removable vena cava filter in order to prevent pulmonary embolism in patients submitted to thrombolysis. Eur Heart J 1990;11:334–341.PubMedGoogle Scholar
  44. 44.
    Greenfield LJ. Current indications for and results of Greenfield filter placement. J Vasc Surg 1984;1:502–504.CrossRefPubMedGoogle Scholar

Copyright information

© Annals of Vascular Surgery Inc. 1994

Authors and Affiliations

  • Wallace C. Tarry
    • 1
  • Raymond G. Makhoul
    • 1
  • Jaime Tisnado
    • 2
  • Marc P. Posner
    • 1
  • Michael Sobel
    • 1
  • H. M. Lee
    • 1
  1. 1.Department of Surgery, Divisions of Vascular and Transplantation Surgery and Interventional RadiologyMedical College of VirginiaRichmond
  2. 2.Department of Radiology, Divisions of Vascular and Transplantation Surgery and Interventional RadiologyMedical College of VirginiaRichmond

Personalised recommendations